Table 6 HDAC-inhibitors in NKTL.

From: NK-/T-cell lymphomas

N Subjects

 

Response

Ref.

16

Chidamide

1 CR/2 PR

[113]

19

2 CR/3 PR

[114]

18

Chidamide/Chemotherapy

2 CR/6 PR

15

Chidamide

4 CR/2 PR

[115]

37

Chitamide/Sintilimab

16 CR/5 PR

[116]

2

Panobinostat/Bortezomib

1 PR

[117]

3

Romidepsin ± Chemotherapy

NA

[119, 121, 122]

2

Belinostat

1 CR/1 PR

[120]

1

Vorinostat

CR

[123]

1

[124]

  1. CR complete remission, PR partial remission.
Back to article page